← Back to Clinical Trials
Recruiting NCT07092111

Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer

Trial Parameters

Condition Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
Sponsor The First Affiliated Hospital with Nanjing Medical University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 110
Sex FEMALE
Min Age 18 Years
Max Age 75 Years
Start Date 2024-07-01
Completion 2025-09
Interventions
Auricular acupuncture treatmentSham acupuncture group

Brief Summary

Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Eligibility Criteria

Inclusion Criteria: * Patients with breast cancer diagnosed with stage I-III; * Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months; * 18 years old≤ age≤ 75 years old, female; * Subjects voluntarily participate in this trial and sign the informed consent form. Exclusion Criteria: * Patients who have had acupuncture treatment in the past; * After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture. * Platelets\< 50,000/μL; * Patients with CIPN≥1 grade 1 (NCI-CTCAE); * Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.

Related Trials